Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3700 3762 3766 3792 3796
This examiner grants 65% of resolved cases
Erica Shengkai Lee is an examiner in Art Unit 3700, within Tech Center 3700. She has 616 resolved cases, providing a substantial amount of data for analysis. The allowance rate for this examiner is 65.4 percent, which is a moderate and balanced figure for applicants. The interview lift is 30.1 percent, suggesting that direct engagement with the examiner is a highly effective way to move an application toward allowance. This 30.1 percent lift is a significant incentive for practitioners to schedule interviews.
The median time to allowance is 1331 days, which is a long prosecution cycle of over three and a half years. This 1331-day timeline, combined with the 65.4 percent allowance rate, highlights the importance of the 30.1 percent interview lift. The lift provides a significant opportunity to improve the odds of success and potentially shorten the prosecution process. With 616 resolved cases, the data shows a clear pattern where direct communication leads to much better outcomes. Practitioners should use the 30.1 percent lift to overcome rejections more efficiently. The 1331-day median pendency remains the primary benchmark for timeline expectations. Overall, the data from Tech Center 3700 indicates that active prosecution is the most effective strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17632922 | SYSTEMS AND METHODS FOR MONITORING NEUTRAL ACTIVITY | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 18461416 | PROVIDING USER PROMPTS CORRESPONDING TO WEARABLE DEVICE SENSOR POSITIONS | Non-Final OA | QUALCOMM Incorporated |
| 18834471 | ACTIVE IMPLANTABLE MEDICAL DEVICE COMPRISING A FILM-LIKE CONNECTING ELEMENT | Final Rejection | BIOTRONIK SE & Co. KG |
| 17999731 | System for Generating an Alert for a Systemic Infection | Non-Final OA | BIOTRONIK SE & Co. KG |
| 19050595 | BLOOD PUMP HOUSING COMPONENT | Non-Final OA | ABIOMED, Inc. |
| 18543910 | POSTURE STATE RESPONSIVE THERAPY DELIVERY USING DWELL TIMES | Non-Final OA | Medtronic, Inc. |
| 18562735 | DYNAMIC AND MODULAR CARDIAC EVENT DETECTION | Final Rejection | Medtronic, Inc. |
| 18546564 | PARAMETER SELECTION FOR ELECTRICAL STIMULATION THERAPY | Non-Final OA | Medtronic, Inc. |
| 18610752 | CONNECTION ARRANGEMENT FOR A SURGICAL INSTRUMENT OR IN A SURGICAL INSTRUMENT | Final Rejection | KARL STORZ SE & Co. KG |
| 18008129 | NON-TRANSITORY COMPUTER-READABLE MEDIUM, PORTABLE INFORMATION TERMINAL, SYSTEM, AND METHOD FOR NOTIFICATION ABOUT ACTIVATION OF AUTOMATED EXTERNAL DEFIBRILLATOR | Non-Final OA | Nihon Kohden Corporation |
| 18008118 | AUTOMATED EXTERNAL DEFIBRILLATOR AND METHOD FOR NOTIFICATION ABOUT ABNORMALITY OF AUTOMATED EXTERNAL DEFIBRILLATOR | Final Rejection | Nihon Kohden Corporation |
| 19271267 | TAILORED NERVE STIMULATION FOR TREMOR | Non-Final OA | Cala Health, Inc. |
| 19271131 | SEPARABLE HOUSING FOR TREMOR REDUCTION SYSTEM | Non-Final OA | Cala Health, Inc. |
| 19270963 | TREMOR REDUCTION USING MACHINE LEARNING ALGORITHMS | Non-Final OA | Cala Health, Inc. |
| 19271273 | TREMOR REDUCTION USING CLOUD COMPUTING | Non-Final OA | Cala Health, Inc. |
| 19029892 | DEVICES AND METHODS FOR CONTROLLING TREMOR | Non-Final OA | Cala Health, Inc. |
| 17808850 | BAND FOR WEARABLE NEUROSTIMULATION SYSTEM | Non-Final OA | Cala Health, Inc. |
| 18741196 | COCHLEAR IMPLANT SYSTEM WITH MEASUREMENT UNIT | Final Rejection | Cochlear Limited |
| 17966009 | ACTIVE CONTROL OF INTRACOCHLEAR STIMULATION | Non-Final OA | Cochlear Limited |
| 17581307 | MOTOR LEARNING AND VAGUS NERVE STIMULATION (VNS) PAIRED WITH MOTOR LEARNING TO TREAT DEMYELINATING DISEASES, CONDITIONS AND DISORDERS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 18090996 | DEVICES AND METHODS FOR BAROREFLEX ACTIVATION | Non-Final OA | CVRx, Inc. |
| 19023780 | DETECTING NONSUSTAINED VENTRICULAR TACHYCARDIA IN A WEARABLE CARDIOVERTER DEFIBRILLATOR | Non-Final OA | West Affum Holdings DAC |
| 17478174 | Methods And Compositions For Treating Coronavirus | Final Rejection | NOVOCURE GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy